Showing results (121-130 of 156) with videos related to
Sort By:
Pageof 16
Radiation Oncology (London, England)|June 3, 2016
Hypo-fractionated stereotactic radiotherapy alone using volumetric modulated arc therapy for patients with single, large brain metastases unsuitable for surgical resectionPierina Navarria, Federico Pessina, Luca Cozzi, et al.Clinical Lung Cancer|November 1, 2025
Clinical Outcomes and Predictive Factors in NSCLC after Surgery: Findings from the RAC-TAC StudyAlessio Bruni, Davide Franceschini, Beatrice Marini, et al.Journal of Cancer Research and Clinical Oncology|January 2, 2021
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study)Fiorenza De Rose, Maria Carmen De Santis, Bruno Meduri, et al.ACS Medicinal Chemistry Letters|June 6, 2014
Fused 3-Hydroxy-3-trifluoromethylpyrazoles Inhibit Mutant Huntingtin ToxicitySalvatore La Rosa, Tiziana Benicchi, Laura Bettinetti, et al.International Journal of Radiation Oncology, Biology, Physics|September 4, 2019
Surgery Followed by Hypofractionated Radiosurgery on the Tumor Bed in Oligometastatic Patients With Large Brain Metastases. Results of a Phase 2 StudyPierina Navarria, Federico Pessina, Elena Clerici, et al.Radiation Oncology (London, England)|February 8, 2023
Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platformMarta Scorsetti, Pierina Navarria, Luca Cozzi, et al.Cancers|September 14, 2024
Predictive Factors for Long-Term Disease Control in Systemic Treatment-Naïve Oligorecurrent Renal Cell Carcinoma Treated with Up-Front Stereotactic Ablative Radiotherapy (SABR)Ciro Franzese, Veronica Vernier, Marco Badalamenti, et al.Current Oncology (Toronto, Ont.)|March 28, 2023
Adaptive Volumetric-Modulated Arc Radiation Therapy for Head and Neck Cancer: Evaluation of Benefit on Target Coverage and Sparing of Organs at RiskCiro Franzese, Stefano Tomatis, Sofia Paola Bianchi, et al.La Radiologia Medica|August 31, 2024
Adjuvant modern radiotherapy in resected pN2 NSCLC patients: results from a multicentre retrospective analysis on acute and late toxicity on behalf of AIRO thoracic oncology study group: the RAC-TAC studyValerio Nardone, Alessio Bruni, Davide Franceschini, et al.Current Oncology (Toronto, Ont.)|November 24, 2022
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)Tiziana Comito, Mauro Loi, Ciro Franzese, et al.Pageof 16